Horie Yoshinori, Ishii Hiromasa, Hibi Toshifumi
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
Alcohol Clin Exp Res. 2005 Dec;29(12 Suppl):251S-8S. doi: 10.1097/01.alc.0000192300.52559.04.
Recently, the incidence of alcoholic liver disease (ALD) has been increasing in Japan; this associated with an increase in alcoholic beverage consumption. Multiple organ failures are frequently observed in patients with severe alcoholic hepatitis (AH), most of whom have a poor prognosis similar to fulminant hepatitis; as well numbers of severe AH patients appear to be increasing. Although prognosis of fulminant hepatitis in Japan has been recently improved by intensive treatments such as plasma exchange (PE) that of severe AH has not changed. The objective of this study was to determine whether there was any factor that could determine the prognosis of severe AH.
We carried out nation-wide survey by asking hospitals certified by the Japanese Society of Gastroenterology and hospitals related to ours hospital for the current status of patients seen with severe alcoholic hepatitis since 1998. We investigated correlations between various factors including blood laboratory data, presence of other organ failure, and prognosis.
Mortality of patients with severe AH was high (66.4%). The ratio of female patients with severe AH (26%) was higher than that for other ALD (approximately 10%). Mean age was older (Alive: 44 +/- 11; Dead: 50 +/- 11 years old), white blood cell (WBC) counts were higher (11600 +/- 5200; 21800 +/- 13400/microl), red blood cell counts were lower (320 +/- 95; 265 +/- 72 x 10/microl) and prothrombin time (PT) was prolonged (36.2 +/- 10.4; 29.1 +/- 9.4%, respectively) in patients who had died than in patients who had survived. However, as all differences diminished after carrying out PE, we analyzed data in patients without PE. The results were similar to those in all patients. Prevalence of infection, gastrointestinal (GI) bleeding and disseminated intravascular coagulation (DIC) was higher in patients who had died. Although intensive treatments such as PE, hemodialysis, and anticoagulation therapy did not change the prognosis of severe AH, PE improved the prognosis of patients without either GI bleeding or DIC. WBC counts were also slightly higher in patients who had died after carrying out PE. Two cases had been cured by granulocytapheresis (GCAP) CONCLUSIONS: PE can compensate for and reduce the risk due to prolonged PT in patients with severe AH. These results suggest that the patients with markedly elevated WBC counts, prolonged PT, or anemia should, if possible, be treated at an earlier stage with an intensive treatment such as PE, hemodialysis, or anticoagulation therapy before infection, GI bleeding or DIC occurs. Further, GCAP might be useful for severe AH patients with higher WBC counts.
近年来,日本酒精性肝病(ALD)的发病率呈上升趋势,这与酒精饮料消费量的增加有关。在重症酒精性肝炎(AH)患者中经常观察到多器官功能衰竭,其中大多数患者的预后与暴发性肝炎相似,预后较差;而且重症AH患者的数量似乎也在增加。尽管近年来日本通过血浆置换(PE)等强化治疗改善了暴发性肝炎的预后,但重症AH的预后并未改变。本研究的目的是确定是否存在任何可决定重症AH预后的因素。
我们通过询问日本胃肠病学会认证的医院以及与我院相关的医院,对自1998年以来收治的重症酒精性肝炎患者的现状进行了全国性调查。我们调查了包括血液实验室数据、其他器官功能衰竭的存在情况以及预后等各种因素之间的相关性。
重症AH患者的死亡率很高(66.4%)。重症AH女性患者的比例(26%)高于其他ALD患者(约10%)。死亡患者的平均年龄较大(存活者:44±11岁;死亡者:50±11岁),白细胞(WBC)计数较高(11600±5200;21800±13400/微升),红细胞计数较低(320±95;265±72×10/微升),凝血酶原时间(PT)延长(分别为36.2±10.4;29.1±9.4%),均高于存活患者。然而,由于在进行PE后所有差异均减小,我们分析了未进行PE患者的数据。结果与所有患者的结果相似。死亡患者感染、胃肠道(GI)出血和弥散性血管内凝血(DIC)的发生率较高。尽管PE、血液透析和抗凝治疗等强化治疗并未改变重症AH的预后,但PE改善了无GI出血或DIC患者的预后。进行PE后死亡患者的WBC计数也略高。有2例患者通过粒细胞单采术(GCAP)治愈。结论:PE可以弥补并降低重症AH患者因PT延长所致的风险。这些结果表明,对于WBC计数明显升高、PT延长或贫血的患者,应尽可能在感染、GI出血或DIC发生之前尽早进行PE、血液透析或抗凝治疗等强化治疗。此外,GCAP可能对WBC计数较高的重症AH患者有用。